Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: My take on the timing of the PR

I believe we have the stock power to do that. Except I think it's more like we need 40 million plus shares. And I still think we have the stock power to do that as well.

Share
New Message
Please login to post a reply